Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

This study aims to expand the CE mark IFU of the SING IMT™ to pseudophakic (patients with an intraocular lents) patients with late stage of AMD (Age-Related Macular Degeneration) and bilateral central vision impairment. This randomized, international, multicenter study will evaluate the safety and efficacy of the device in this patient group. Findings will support regulatory submissions, clinical decision-making, and potential label expansion.

Participants needed: 44
Trial details
Age: 55+Biological sex: AllType: InterventionalSponsor: VisionCare, Inc.Updated: Mar 20, 2026Locations: 12
Eligibility criteria

Be 55 years of age or older; [+10]

Evidence of active choroidal neovascularization (CNV), or treatment for CNV with... [+25]

Read more
Status: Recruiting

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

The objective of this study is to demonstrate the safety and effectiveness of the SING IMT (Smaller Incision New Generation Implantable Miniature Telescope) 3X implant in improving vision in patients with central vision impairment associated with end-stage Age-related Macular Degeneration (AMD). Eligible patients will be implanted with the SING IMT device and will be followed-up for a period of 12-months with post-operative ophthalmic exams and low-vision rehabilitation sessions.

Participants needed: 76
Trial details
Age: 55+Biological sex: AllType: InterventionalSponsor: VisionCare, Inc.Updated: Feb 10, 2026Locations: 13
Eligibility criteria

Be 55 years of age or older. [+9]

Evidence of active choroidal neovascularization (CNV) on fluorescein angiography... [+26]

Read more
Status: Recruiting

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).

Participants needed: 125
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: VisionCare, Inc.Updated: Dec 3, 2024Locations: 10
Eligibility criteria

Be at least 65 years of age at the Pre-operative Visit; [+9]

Have cognitive impairment that would interfere with the ability to understand an... [+27]

Read more